Grünenthal Limited
TOR Building
St Cloud Way
Maidenhead SL6 8BN
Phone: +44 (0)870 351 8960

For Medical Information, Reporting Safety and Quality Related Issues see here

... About us

We are an independent, family-owned company with headquarters in Aachen, Germany. We are present in 29 countries with affiliates in Europe, Latin America and the USA. Our products are sold in more than 100 countries and we employ around 4,700 employees worldwide.

... Company Overview

Although firmly rooted in Germany, today we are very much a growing global business.

... History

At Grünenthal, conducting our business responsibly is a core part of our company’s strategy and culture. As a global leader in pain management, Grünenthal aspires to create a positive impact on society – in our core business and beyond. We are guided by integrity, transparency and the highest ethical standards.

... Responsibility

Although firmly rooted in Germany, today we’re very much a growing global business, represented in 27 countries and maintaining production sites in five.

... Global Capabilities

We are dedicated to creating a better future for our patients, so getting involved with diverse initiatives that support this goal is vital.

... Initiatives

... Requests for Funding

Patients’ needs are at the heart of everything we do; using our passion for science, we develop long-lasting solutions that directly address these needs.

... Products

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Ationdo.

... Ationdo

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Nebido.

... Nebido

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Palexia.

... Palexia

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Qutenza.

... Qutenza

We are dedicated to creating a better future for our patients, Read the package leaflet information to find out more about Ralvo.

... Lidocaine Grunenthal

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Tramacet.

... Tramacet

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Versatis.

... Versatis

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Vimovo .

... Vimovo

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Zydol.

... Zydol

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Zomig.

... Zomig

Patients’ needs are at the heart of everything we do; using our passion for science, we develop long-lasting solutions that directly address these needs. Read the package leaflet information to find out more about our products.

... Reporting Safety and Quality Related complaints

The world needs better pain treatments

Pain is widely considered as one of the biggest problems in medicine today: a 2016 UK-based review indicates that an estimated 28 million adults in the UK suffer from chronic pain ¹. Adequate treatment is often unavailable or hard to access, and as a specialist business focused on this market niche, we’re determined to tackle this problem.

¹ Fayaz A, Croft P, Langford RM, et al. Prevalence of chronic pain in the UK: a systematic review and meta-analysis of population studies. BMJ Open 2016;6:e010364.doi:10.1136/bmjopen-2015-010364

“Imagine going through your daily life where everything that you touch, or that touches you, where almost every noise around you from a passing car to children playing, causes you pain. We will leave no stone unturned to help these patients.”

Gabriel Baertschi

Chief Executive Officer

Our purpose is to change lives for the better. We believe that change is possible. We invest heavily in innovation, exploring new possibilities to develop smart solutions. Success comes from pioneering treatments that transform patients’ lives for the better. This measure of success drives everything we do.

Our strategy: leading with innovation

We focus our R&D activities on pain and have built up our portfolio with projects beyond pain and medical devices. This diversifies our risks and opens new markets for us.

“As a worldwide leader in pain management, we are looking for strategic partnerships in research and development to bring innovative solutions to patients with indications with high unmet medical needs. Innovation is at our core and as a fully integrated pharmaceutical company, we can offer support along the whole value chain – from drug development to commercialisation.”

Gabriel Baertschi

Chief Executive Officer

Get to know us

Grunenthal Ltd., UK, a subsidiary of Grunenthal GmBH, was established in 2004. With headquarters in Maidenhead, the company includes Regulatory, Medical Information, Sales and Marketing divisions as well as Market Access and Medical Science Liaison teams.

Grunenthal Ltd., UK currently markets medications for relief or management of moderate to severe pain including peripheral neuropathic pain to GPs, hospital doctors, pharmacists and nurses.

Grünenthal by the numbers

We are an independent, family-owned company with headquarters in Aachen, Germany. We are present in 27 countries with affiliates in Europe, Latin America and the USA.

Leadership

A mix of strong entrepreneurial spirit, close collaboration and outstanding performance define our approach alongside a commitment to diversity and inclusivity.

Ready to create a brighter future for our patients? - Work with Grünenthal

Join us

Imaginative researcher? Unconventional strategist? Forward-thinking go-getter? We would love to hear from you.

M-NA-UK-03-24-0032 - March 2024